| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab177865-100μg |
100μg |
现货  |
| |
| Ab177865-1mg |
1mg |
现货 |
| |
| Ab177865-5mg |
5mg |
现货 |
| |
| Ab177865-10mg |
10mg |
期货 |
|
| 产品名称 | AMG 108 (anti-IL-1R1) |
|---|---|
| 别名 | AMG 108（抗 IL-1R1） |
| 英文别名 | CD121 antigen-like family member A | EC 3.2.2.6 | IL-1R-1 | IL-1R-alpha | IL-1RT1 | IL-1RT-1 | Interleukin-1 receptor alpha | Interleukin-1 receptor type I | p80 |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | IL1R1 |
| 种属反应性 | 人(Human) |
| 偶联 | Unconjugated |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG2 |
| 轻链亚型 | kappa |
| SDS-PAGE | 145.5 kDa |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| 分子类型 | 抗体 |
AMG 108 (anti-IL-1R1) (Ab177865) - Flow Cytometry
Flow Cytometry analysis of HeLa cells labelling IL-1R1 (red) with AMG 108 (anti-IL-1R1) (Ab177865). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
AMG 108 (anti-IL-1R1) (Ab177865) - SEC
The purity of AMG 108 (anti-IL-1R1) (Ab177865) is more than 95% verified by HPLC.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
 ZJ24F1013245 |
分析证书 | 24-11-01 | Ab177865 |
| ZJ24F1013244 |
分析证书 | 24-11-01 | Ab177865 |
| ZJ24F1013243 |
分析证书 | 24-11-01 | Ab177865 |
| 1. Dripps DJ, Verderber E, Ng RK, Thompson RC, Eisenberg SP. (1991) Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils.. J Biol Chem, 266 (30): (20311-5). [PMID:1834644] |
| 2. Schreuder H, Tardif C, Trump-Kallmeyer S, Soffientini A, Sarubbi E, Akeson A, Bowlin T, Yanofsky S, Barrett RW. (1997) A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.. Nature, 386 (6621): (194-200). [PMID:9062194] |
| 3. Haile PA, Votta BJ, Marquis RW, Bury MJ, Mehlmann JF, Singhaus Jr R, Charnley AK, Lakdawala AS, Convery MA, Lipshutz DB et al.. (2016) The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase.. J Med Chem, 59 (10): (4867-80). [PMID:27109867] |
| 4. Kovalchin J, King B, Masci A, Hopkins E, Fry J, Hou J, Li C, Tenneson K, Weber S, Wolfe G et al.. (2018) Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases.. Eye Contact Lens, 44 (3): (170-181). [PMID:28727604] |
| 5. Giri JG, Wells J, Dower SK, McCall CE, Guzman RN, Slack J, Bird TA, Shanebeck K, Grabstein KH, Sims JE et al.. (1994) Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.. J Immunol, 153 (12): (5802-9). [PMID:7989776] |
| 6. Haile PA, Casillas LN, Votta BJ, Wang GZ, Charnley AK, Dong X, Bury MJ, Romano JJ, Mehlmann JF, King BW et al.. (2019) Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases.. J Med Chem, 62 (14): (6482-6494). [PMID:31265286] |
| 7. Zhang L, Shi L, Soars SM, Kamps J, Yin H.. (2018) Discovery of Novel Small-Molecule Inhibitors of NF-κB Signaling with Antiinflammatory and Anticancer Properties.. J Med Chem, 61 (14): (5881-5899). [PMID:29870245] [10.1021/acs.jmedchem.7b01557] |
| 8. Knoepfel T, Nimsgern P, Jacquier S, Bourrel M, Vangrevelinghe E, Glatthar R, Behnke D, Alper PB, Michellys PY, Deane J, Junt T, Zipfel G, Limonta S, Hawtin S, Andre C, Boulay T, Loetscher P, Faller M, Blank J, Feifel R, Betschart C.. (2020) Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay.. J Med Chem, 63 (15): (8276-8295). [PMID:32786235] [10.1021/acs.jmedchem.0c00130] |
| 9. Sims, J E JE and 6 more authors.. (1989) Cloning the interleukin 1 receptor from human T cells.. Proceedings of the National Academy of Sciences of the United States of America, [PMID:2530587] |
| 10. Chua, A O AO and Gubler, U U.. (1989) Sequence of the cDNA for the human fibroblast type interleukin-1 receptor.. Nucleic acids research, (11): [PMID:2532321] |
| 11. Vigers, G P GP, Anderson, L J LJ, Caffes, P P and Brandhuber, B J BJ.. (1997) Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.. Nature, (13): [PMID:9062193] |
| 12. Huang, J J, Gao, X X, Li, S S and Cao, Z Z.. (1997) Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein.. Proceedings of the National Academy of Sciences of the United States of America, (25): [PMID:9371760] |
| 13. Vannier, E E and 6 more authors.. (1999) Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy.. European cytokine network, [PMID:10210771] |
| 14. Tominaga, K K and 7 more authors.. (2000) IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells.. International immunology, [PMID:10653850] |
| 15. Vigers, G P GP, Dripps, D J DJ, Edwards, C K CK and Brandhuber, B J BJ.. (2000) X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1.. The Journal of biological chemistry, (24): [PMID:10903327] |
| 16. Vamvakopoulos, Joannis J, Green, Colin C and Metcalfe, Su S.. (2002) Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist.. European journal of immunology, [PMID:12355453] |
| 17. and Dayer, J M JM.. (2003) The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.. Rheumatology (Oxford, England), [PMID:12817089] |
| 18. Do, Herve H and 12 more authors.. (2006) Exhaustive genotyping of the interleukin-1 family genes and associations with AIDS progression in a French cohort.. The Journal of infectious diseases, (1): [PMID:17083033] |
| 19. So, Alexander A, De Smedt, Thibaut T, Revaz, Sylvie S and Tschopp, Jürg J.. (2007) A pilot study of IL-1 inhibition by anakinra in acute gout.. Arthritis research & therapy, [PMID:17352828] |
| 20. Tang, Ying-hong YH, Zhang, Shu-ping SP, Liang, Yan Y and Deng, Chang-qing CQ.. (2007) [Effects of Panax notoginseng saponins on mRNA expressions of interleukin-1 beta, its correlative factors and cysteinyl-aspartate specific protease after cerebral ischemia-reperfusion in rats].. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, [PMID:17498496] |
首页
400-620-6333
